Advanced Medical Solutions Group PLC
LSE:AMS
P/B
Price to Book Value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
Market Cap | P/B | ||||
---|---|---|---|---|---|
UK |
Advanced Medical Solutions Group PLC
LSE:AMS
|
442.3m GBP | 1.8 | ||
JP |
Hoya Corp
TSE:7741
|
6.3T JPY | 7.2 | ||
CH |
Alcon AG
SIX:ALC
|
36.3B CHF | 1.9 | ||
DK |
Coloplast A/S
CSE:COLO B
|
190B DKK | 12.6 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 5.4 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.8B USD | 2.4 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | 25 | |
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 8.1 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 4 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 1.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 0.8 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.